missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human IL-17E (IL-25) Recombinant Protein, eBioscience™

Recombinant Protein

£90.25 - £584.00

Specifications

Accession Number Q9H293
Formulation 0.01M acetic acid with no preservative
Gene ID (Entrez) 64806
Molecular Weight (g/mol) 33.8kDa disulfide-linked homodimer of two 145 aa polypeptide chains
Name Human IL-17E (IL-25) Carrier-Free
View More Specs

Products 3
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15518836
View Documents Promotion Details
Invitrogen™
34-8736-82
100μg
£584.00
100µg
View alternative products
Save Up to 
»
Estimated Shipment: 06-06-2024
to see stock.
Please to purchase this item. Need a web account? Register with us today!
15508836
View Documents Promotion Details
Invitrogen™
34-8736-80
25μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A View alternative products
Save Up to 
»
15598826
View Documents Promotion Details
Invitrogen™
34-8736-62
5μg This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
N/A View alternative products
Save Up to 
»
Description

Description

Interleukin 25 (IL-25) is a member of the IL-17 family and is identified as a proinflammatory cytokine which is produced by Th17 effector cells thus enabling the Th17 subset to initiate or maintain the autoimmune process in diseases such as Rheumatoid Arthritis. IL-25 also induces activation of NF-kappa-B and stimulates production of the proinflammatory chemokine IL-8. IL-25 itself is activated through IL-23, IL-5, and TGF-beta. Description: IL-17E, or IL-25, was first identified as an IL-17 family member on the basis of sequence homology. It was originally believed to be a Th2 cytokine based on the detection of mRNA transcripts in polarized Th2 cells, but expression was later observed in epithelial cells, eosinophils, and mast cells. Studies have confirmed the role of IL-17E as a potent inducer of type 2 immune responses. IL-17E signaling induces the differentiation of CD4+ T cells towards the Th2 lineage and upregulates expression of Th2 cytokines such as IL-4, IL-5, and IL-13. Administration of IL-17E also promotes symptoms of allergic asthma, such as eosinophil infiltration, airway hyperreactivity, and high circulating levels of IgE. IL-17E binds to IL-17BR, a receptor shared with IL-17B, and activates NF-kappa B pathways. Applications Reported: This protein (10-100 ng) can to induce IL-8 secretion from normal human peripheral blood cells. Applications Tested: Recombinant IL-17E (IL-25) is biologically active and can promote IL-8 secretion from human PBMCs. Source: E. coli (amino acids Met17-Gly; accession &Num; AAI04930.1). Bioactivity: This protein (10-100 ng) can to induce IL-8 secretion from normal human peripheral blood cells. Endotoxin: Less than 0.1ng/ug cytokine as determined by the LAL assay. Purity: >98% as determined by SDS-PAGE and HPLC. Molecular Weight: 33.8 kDa disulfide-linked homodimer of two 145 aa polypeptide chains. Storage and handling: For best recovery, quick spin vial prior to opening. Use in sterile environment. Reconstitute in water to a concentration of 0.1-1.0mg/mL. Do not vortex.
Specifications

Specifications

Q9H293
64806
Human IL-17E (IL-25) Carrier-Free
E. coli
RUO
Less than 0.1ng/μg cytokine as determined by the LAL assay
IL25
Human
Hu
Recombinant
Recombinant
0.01M acetic acid with no preservative
33.8kDa disulfide-linked homodimer of two 145 aa polypeptide chains
SDS-PAGE and HPLC
-20°C
E. coli (amino acids Met17-Gly; Accession # AAI04930.1)
Human IL-17E (IL-25) Carrier-Free
This protein (10-100 ng) can to induce IL-8 secretion from normal human peripheral blood cells.
Unconjugated
E. coli
Lyophilized
Affinity chromatography
Videos
SDS
Documents

Documents

Product Certifications